Tevogen Bio Holdings (TVGN) Restructuring Costs (2024)
Tevogen Bio Holdings (TVGN) reported Restructuring Costs of $7.5 million for Q1 2024.
Tevogen Bio Holdings (TVGN) Restructuring Costs (2024) Analysis & Trends
Tevogen Bio Holdings has reported Restructuring Costs for 1 years, with the latest figure at $7.5 million in Q1 2024.
- For the quarter ending Q1 2024, Restructuring Costs changed N/A year-over-year to $7.5 million; the trailing twelve-month figure through Dec 2024 stood at $7.5 million (changed N/A YoY), and the FY2024 full-year result was $7.5 million, changed N/A from the prior year.
- Restructuring Costs for Q1 2024 stood at $7.5 million.
- The five-year high for Restructuring Costs was $7.5 million in Q1 2024, with the low at $7.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 7.50 Mn |